EB

Elizabeth Bruckheimer

VP & Chief Scientific Officer at Panbela Therapeutics

Dr. Elizabeth Bruckheimer joined Panbela as Vice President and Chief Scientific Officer in June 2022. Her professional career spans 20 years in oncology research, the biotech/pharmaceutical industry, and contract research organizations. In those endeavors, she led cross-functional preclinical/translational drug development programs, laboratory/organizational operations, regulatory affairs, project management, and business development activities.